Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| bulky prostate |
|
Total Androgen Suppression Augments 3D-CRT, IMRT Strategies 1 This study randomized men with bulky prostate cancers to either 2 months of goserelin and flutamide treatment followed by external-beam radiation (with Treatment of Locally Advanced Prostate Cancer: Is Chemotherapy the J Urol160:1754-1760, 1998Medline; Green N, Bodner H, Broth E, et al: Improved control of bulky prostate carcinoma with sequential estrogen and radiation Versatile Prostate Cancer Treatment with Inducible Caspase and C and D, starting at 16 weeks of age, TRAMP mice were examined weekly for bulky prostate tumors or signs of distress, requiring euthanasia. Improved control of bulky prostate carcinoma with sequential Patients with bulky prostate cancer have usually been treated by palliative measures because the likelihood of tumor control with definitive irradiation has Neoadjuvant hormonal therapy in carcinoma of the prostate bulky prostate carcinoma with sequential estrogen and. (apoptotic) cell death during the progression and therapy. radiation therapy. Urologia Polska 1995/48/1 - T3pT3 PROSTATE CANCER Prostate cancer is becoming the most important male cancer in EuropÉ. are not enthusiastic to embark on irradiation for a bulky prostate tumor. PII: S0009-9260(96)80247-9 The prostate was found to be enlarged and. small cell carcinoma was shown on biopsy. A CT scan at presentation. showed a bulky prostate (Fig. Prostate Cancer Treatment Can Speed Heart Attacks - washingtonpost.com Men who benefit most are those with "aggressive, bulky prostate cancers," according to Horwitz. "The benefits for them still outweigh the risk in terms of Prostate Cancer and Prostatic Diseases - Prostatic abscess due to A digital rectal examination revealed a soft bulky prostate. The laboratory test revealed an inflammation state (CRP=165, leucocytes: 17 000/ml with high Prostate brachytherapy. An overview in the prostate by hormonal methods before external. beam radiation therapy was givenz5. Brachytherapy in Bulky Prostate Cancer Energy Citations Database (ECD) - - Document #6578741 Title, Improved control of bulky prostate carcinoma with sequential estrogen and Between 1975 and 1980, 25 patients with bulky prostate cancer received |
| bulky prostate |
|
cause prostate die from prostate cancer alberta canada massage prostate cancer condition more prostate treatment |